Stock futures were pointing to a lower opening on heightened U.S. and European debt concerns and following disappointing results from technology bellwether Cisco.

Here are some early-market movers for Thursday.

Dendreon Corp. (NASDAQ: DNDN)

Shares of the biotechnology company were up 6% in pre-market trading after a Medicare advisors agency released a assessment that showed "moderate" support for use of the Provenge prostate cancer vaccine.

Aegean Marine Petroleum Network (NYSE: ANW)

Shares of the Greek fuel shipping company fell 40.2% in pre-market trading Thursday following third-quarter results. The company posted earnings of 10 cents per share on revenue of $1.34 billion. Analysts had been looking for earnings of 35 cents per share and revenue of $1.42 billion.

SurModics Inc (NASDAQ: SRDX)

The drug delivery technology company swung to a surprise fourth-quarter loss sending shares down 36.5% in pre-market trading Thursday. After the close Wednesday the company posted a loss excluding items of five cents per share missing analyst estimates of earnings of 13 cents per share.

Cisco Systems Inc (NASDAQ: CSCO)

Shares of the network technology company sank 16.4% in pre-market trading Thursday despite beating first-quarter expectations late Thursday. The company reported non-GAAP earnings of 42 cents per share beating estimates of 40 cents per share but full year revenue guidance was below current expectations sending shares down.

Concur Technologies Inc (NASDAQ: CNQR)

After the close Wednesday, the employee expense reporting solutions company posted fourth-quarter non-GAAP earnings of six cents per share, in-line with estimates. First-quarter guidance came in below expectations however sending shares down 11.3% in pre-market trading Thursday.

Rosetta Stone Inc. (NYSE: RST)

The language learning systems provider posted mixed third-quarter results reporting non-GAAP earnings of one cent per share which beat estimates of a loss of six cents per share. Revenue of $60.9 million fell short of estimates of $62.7 million. And fourth quarter guidance was below current estimates.